A study looks at the mechanisms behind genetic variation in the bacteria that cause Lyme disease. Lyme disease is the most common vector-transmitted disease in the United States, with around 476,000 human cases annually.
Nuvation inks all-stock deal for US-China oncology biotech AnHeart
Nuvation Bio plans to buy AnHeart Therapeutics in an all-stock deal, the cancer drug developers said Monday morning, in a move that could turn Nuvation